Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rxsight Inc (NQ: RXST )

46.16 -3.62 (-7.27%)
Streaming Delayed Price Updated: 12:00 PM EDT, Jul 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rxsight Inc

< Previous 1 2 3 4 Next >
Breaking Down RxSight: 5 Analysts Share Their Views
Via Benzinga
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
Analyst Expectations for RxSight's Future
Via Benzinga
RxSight: Q3 Earnings Insights
Via Benzinga
Where RxSight Stands With Analysts
Via Benzinga
RxSight's Earnings: A Preview
Via Benzinga
The Latest Analyst Ratings for RxSight
Via Benzinga
Analyst Expectations for RxSight's Future
Via Benzinga
RxSight, Inc. Reports Third Quarter 2023 Financial Results
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Educational and Product Announcements for AAO 2023
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023
From RxSight, Inc.
Via GlobeNewswire
Looking Into RxSight's Return On Capital Employed
Via Benzinga
5 Analysts Have This to Say About RxSight
Via Benzinga
Earnings Preview: RxSight
Via Benzinga
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
RxSight, Inc. Reports Second Quarter 2023 Financial Results
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023
From RxSight, Inc.
Via GlobeNewswire
RxSight Is A Potential Acquisition Target: Analyst Highlights How LAL Revenue Mix Could Drive Share Price To $45+
Needham analyst David Saxon reiterated a Buy rating on RxSight, Inc. (NASDAQ: RXST),  
Via Benzinga
RxSight, Inc. Reports First Quarter 2023 Financial Results
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Present at the Bank of America Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023
From RxSight, Inc.
Via GlobeNewswire
Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting
From RxSight, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023
Via Benzinga
RxSight, Inc. to Present at the Needham Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Present at the Oppenheimer Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of its Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.